{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:35Z","timestamp":1761519095994},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/bf03345683","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T18:55:48Z","timestamp":1397156148000},"page":"74-78","source":"Crossref","is-referenced-by-count":15,"title":["Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction"],"prefix":"10.1007","volume":"32","author":[{"given":"M. L.","family":"Tanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ultimieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gandolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Dalle","family":"Mule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bogazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Broglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bartalena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,22]]},"reference":[{"key":"BF03345683_CR1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656\u201360.","journal-title":"Nature"},{"key":"BF03345683_CR2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/er.2002-0029","volume":"25","author":"AJ Lely Van der","year":"2004","unstructured":"Van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25: 426\u201357.","journal-title":"Endocr Rev"},{"key":"BF03345683_CR3","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1530\/eje.0.143R007","volume":"143","author":"LM Seoane","year":"2000","unstructured":"Seoane LM, Tovar S, Baldelli R, et al. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur J Endocrinol 2000, 143: R7\u20139.","journal-title":"Eur J Endocrinol"},{"key":"BF03345683_CR4","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1210\/jcem.86.9.8002","volume":"86","author":"Y Hataya","year":"2001","unstructured":"Hataya Y, Akamizu T, Takaya K, et al. A low dose of Ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001, 86: 4552\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR5","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","volume":"86","author":"AM Wren","year":"2001","unstructured":"Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001, 86: 5992.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR6","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1210\/jc.2003-031964","volume":"89","author":"F Broglio","year":"2004","unstructured":"Broglio F, Gottero C, Prodam F, et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 2004, 89: 3062\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR7","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1210\/jc.2004-0363","volume":"89","author":"C Gauna","year":"2004","unstructured":"Gauna C, Meyler FM, Janssen JA, et al. Administration of acylated ghrelin reduces insulin sensivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensivity. J Clin Endocrinol Metab 2004, 89: 5035\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","volume":"407","author":"M Tsch\u00f6p","year":"2000","unstructured":"Tsch\u00f6p M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000, 407: 908\u201313.","journal-title":"Nature"},{"key":"BF03345683_CR9","doi-asserted-by":"crossref","first-page":"RC4","DOI":"10.1007\/BF03346290","volume":"30","author":"C Rigault","year":"2007","unstructured":"Rigault C, Le Borgne F, Georges B, Demarquoy J. Ghrelin reduces hepatic mitochondrial fatty acid \u03b2 oxidation. J Endocrinol Invest 2007, 30: RC4\u20138.","journal-title":"J Endocrinol Invest"},{"key":"BF03345683_CR10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","volume":"50","author":"M Tsch\u00f6p","year":"2001","unstructured":"Tsch\u00f6p M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50: 707\u20139.","journal-title":"Diabetes"},{"key":"BF03345683_CR11","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1210\/jc.2002-021669","volume":"88","author":"J Nedv\u00eddkov\u00e1","year":"2003","unstructured":"Nedv\u00eddkov\u00e1 J, Krykorkov\u00e1 I, Bart\u00e1k V, et al. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab 2003, 88: 1678\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.0300-0664.2001.01456.x","volume":"56","author":"TK Hansen","year":"2002","unstructured":"Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002, 56: 203\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03345683_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/0003-4819-139-3-200308050-00018","volume":"139","author":"JE Silva","year":"2003","unstructured":"Silva JE. The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med 2003, 139: 205\u201313.","journal-title":"Ann Intern Med"},{"key":"BF03345683_CR14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jc.2002-021302","volume":"88","author":"AL Riis","year":"2003","unstructured":"Riis AL, Hansen TK, M\u00f8ller N, Weeke J, J\u00f8rgensen JO. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab 2003, 88: 853\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/eje.1.01934","volume":"153","author":"O Gim\u00e9nez-Palop","year":"2005","unstructured":"Gim\u00e9nez-Palop O, Gim\u00e9nez-Perez G, Mauricio D, et al. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur J Endocrinol 2005, 153: 73\u20139.","journal-title":"Eur J Endocrinol"},{"key":"BF03345683_CR16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1089\/thy.2006.16.1259","volume":"16","author":"AE Altinova","year":"2006","unstructured":"Altinova AE, Toruner F, Karakoc A, et al. Serum Ghrelin Levels in patients with Hashimoto\u2019s thyroiditis. Thyroid 2006, 16: 1259\u201364.","journal-title":"Thyroid"},{"key":"BF03345683_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000092603","volume":"65","author":"AE Altinova","year":"2006","unstructured":"Altinova AE, T\u00f6r\u00fcner FB, Akt\u00fcrk M, et al. Reduced serum acylated ghrelin levels in patients with hyperthyroidism. Horm Res 2006, 65: 295\u20139.","journal-title":"Horm Res"},{"key":"BF03345683_CR18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2265.2007.03093.x","volume":"68","author":"AM Manuchehri","year":"2008","unstructured":"Manuchehri AM, Sathyapalan T, Jayagopal V, et al. Alterations in thyroid status do not affect plasma peptide YY (PYY) and ghrelin concentrations. Clin Endocrinol (Oxf) 2008, 68: 836\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03345683_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/ENDO:27:1:055","volume":"27","author":"S R\u00f6jdmark","year":"2005","unstructured":"R\u00f6jdmark S, Calissendorff J, Danielsson O, Brismar K. Hunger-satiety signals in patients with Graves\u2019 thyrotoxicosis before, during and after long-term pharmacological treatment. Endocrine 2005, 27: 55\u201361.","journal-title":"Endocrine"},{"key":"BF03345683_CR20","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2007-2619","volume":"93","author":"S Gjedde","year":"2008","unstructured":"Gjedde S, Vestergaard ET, Gormsen LC, et al. Serum Ghrelin levels are increased in hypothyroid patients and became normalized by L-thyroxine treatment. J Clin Endocrinol Metab 2008, 93: 2277\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2265.2007.02959.x","volume":"67","author":"D Campana","year":"2007","unstructured":"Campana D, Nori F, Pagotto U, et al. Plasma acylated gherlin levels are higher in patients with chronic atrophic gastritis. Clin Endocrinol (Oxf) 2007, 67: 761\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03345683_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/eje.0.1470159","volume":"147","author":"JE Caminos","year":"2002","unstructured":"Caminos JE, Seoane LM, Tovar SA, Casanueva FF, Dieguez C. Influence of thyroid status and growth hormone deficiency on ghrelin. Eur J Endocrinol 2002, 147: 159\u201363.","journal-title":"Eur J Endocrinol"},{"key":"BF03345683_CR23","doi-asserted-by":"crossref","first-page":"RC22","DOI":"10.1007\/BF03350806","volume":"30","author":"LM Seoane","year":"2007","unstructured":"Seoane LM, Al-Massadi O, Barreiro F, Dieguez C, Casanueva FF. Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system. J Endocrinol Invest 2007, 30: RC22\u20135.","journal-title":"J Endocrinol Invest"},{"key":"BF03345683_CR24","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1210\/jcem.87.8.8879","volume":"87","author":"MF Saad","year":"2002","unstructured":"Saad MF, Bernaba B, Hwu, CM et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002, 87: 3997\u20134000.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1530\/eje.0.1510573","volume":"151","author":"A Katsuki","year":"2004","unstructured":"Katsuki A, Urakawa H, Gabazza EC, et al. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur J Endocrinol 2004, 151: 573\u20137.","journal-title":"Eur J Endocrinol"},{"key":"BF03345683_CR26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF03347446","volume":"30","author":"A Kempa","year":"2007","unstructured":"Kempa A, Krzyzanowska-Swiniarska B, Miazgowski T, Pilarska K. Not insulin but insulin sensivity, leptin and cortisol are major factors regulating serum acylated ghrelin level in healthy women. J Endocrinol Invest 2007, 30: 659\u201365.","journal-title":"J Endocrinol Invest"},{"key":"BF03345683_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diabetes.52.1.16","volume":"52","author":"G Schaller","year":"2003","unstructured":"Schaller G, Schmidt A, Pleiner J, Woloszczuk W, Wolzt M, Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin. Diabetes 2003, 52: 16\u201320.","journal-title":"Diabetes"},{"key":"BF03345683_CR28","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1210\/jcem.87.4.8538","volume":"87","author":"A Caix\u00e1s","year":"2002","unstructured":"Caix\u00e1s A, Bashore C, Nash W, Pi-Sunyer F, Laferr\u00e8re B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 2002, 87: 1902\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345683_CR29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/BF03346332","volume":"30","author":"M Serra-Prat","year":"2007","unstructured":"Serra-Prat M, Fern\u00e1ndez X, Burdoy E, et al; Matar\u00f3 Ageing Study Group. The role of ghrelin in the energy homeostasis of elderly people: a population-based study. J Endocrinol Invest 2007, 30: 484\u201390.","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345683.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345683\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:25:55Z","timestamp":1558520755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BF03345683"],"URL":"https:\/\/doi.org\/10.1007\/bf03345683","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}